8-103371717-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138455.4(CTHRC1):c.61C>G(p.Leu21Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,536,242 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138455.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CTHRC1 | NM_138455.4 | c.61C>G | p.Leu21Val | missense_variant | 1/4 | ENST00000330295.10 | |
CTHRC1 | XM_011516824.3 | c.61C>G | p.Leu21Val | missense_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CTHRC1 | ENST00000330295.10 | c.61C>G | p.Leu21Val | missense_variant | 1/4 | 1 | NM_138455.4 | P1 | |
CTHRC1 | ENST00000415886.2 | c.61C>G | p.Leu21Val | missense_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000105 AC: 16AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000771 AC: 10AN: 129736Hom.: 0 AF XY: 0.000113 AC XY: 8AN XY: 70674
GnomAD4 exome AF: 0.000372 AC: 515AN: 1384060Hom.: 1 Cov.: 31 AF XY: 0.000358 AC XY: 244AN XY: 682198
GnomAD4 genome ? AF: 0.000105 AC: 16AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.0000942 AC XY: 7AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.61C>G (p.L21V) alteration is located in exon 1 (coding exon 1) of the CTHRC1 gene. This alteration results from a C to G substitution at nucleotide position 61, causing the leucine (L) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at